SecurityMD / Mednax, Inc.
InstitutionFNY Managed Accounts LLC
Shares2,500
Value $ 139,000

FNY Managed Accounts LLC ownership in MD / Mednax, Inc.

April 18, 2018 - FNY Managed Accounts LLC has filed a 13F-HR/A form disclosing ownership of 2,500 shares of Mednax, Inc. (NYSE:MD) with total holdings valued at $139,000 USD as of March 31, 2018. FNY Managed Accounts LLC had filed a previous 13F-HR on November 09, 2017 disclosing 0 shares of Mednax, Inc. at a value of $0 USD.

Other investors with positions similar to FNY Managed Accounts LLC include LS Investment Advisors, LLC, First Bank & Trust, Fifth Third Bancorp, QS Investors, LLC, Tower Research Capital LLC (TRC), and First Quadrant L P/ca.

Mednax, Inc. has declared a standard industrial code (sic) of 806 which is the "Hospitals" industry. FNY Managed Accounts LLC's top industries are "Agricultural Services" (sic 07), "Motion Pictures and Film" (sic 78), and "Insurance Agents, Brokers, And Service" (sic 64).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-03-31 13F-HR/A-1 MEDNAX ORD COM 58502B106 2,500 139
2018-03-31 13F-HR MEDNAX ORD COM 58502B106 2,500 139
2017-09-30 13F-HR MEDNAX ORD COM 58502B106 0 -100.00 0 -100.00
2017-06-30 13F-HR MEDNAX ORD COM 58502B106 62.07 246 3.36 14 -12.50 0 -2 -15.60
2017-03-31 13F-HR/A-2 MEDNAX ORD COM 58502B106 67.23 238 0.00 16 0.00 0 0 0.00
2017-03-31 13F-HR/A-1 MEDNAX ORD COM 58502B106 67.23 238 0.00 16 0.00 0 0 0.00
2017-03-31 13F-HR MEDNAX ORD COM 58502B106 238 16

Related SEC Filings

MD / Mednax, Inc. / Elliott Associates, L.P. - MEDNAX, INC. (Activist Investment)

2018-09-20 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

MD / Mednax, Inc. / Elliott Associates, L.P. - MEDNAX, INC. (Activist Investment)

2018-09-20 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

MD / Mednax, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7) MEDNAX, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 58502B106 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

MD / Mednax, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7) MEDNAX, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 58502B106 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

MD / Mednax, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 1 MEDNAX INC COMMON STOCK Cusip #58502B106 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #58502B106 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,475,288 Item 6: 0 Item 7: 3,876,210 Item 8: 0 Item 9: 3,876,210 Item 11: 4.138% Item 12: HC Cusip #58502B106 Item 1: Reporting Person - Abigail P.

Related News Stories

MEDNAX Buys Radiology Specialists to Expand Business

2018-10-03 zacks
MEDNAX, Inc. (MD - Free Report) has acquired Radiology Specialists, a private radiology physician group based in Las Vegas. (3-0)

Should Value Investors Consider MEDNAX (MD) Stock Now?

2018-09-26 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.

MEDNAX (MD) Unveils Unit for Better Pediatric Hearing Care

2018-09-14 zacks
MEDNAX, Inc. (MD - Free Report) , the country’s leading provider of newborn hearing screen services, recently launched the MEDNAX Audiology Institute for innovation and partnership across all aspects of pediatric hearing loss. This will cover early detection of hearing loss, diagnosis and treatment along with access to better care. The parent company’s largest provider of maternal-fetal, newborn and pediatric subspecialty services, namely Pediatrix Medical Group, Inc.

Huge Opportunity With This Profitable Medical Company

2018-09-14 seekingalpha
Accelerated share repurchase program will compound with the firm's growth to give some very nice headlines on EPS growth, driving valuation upward.

MEDNAX (MD) Q2 2018 Results - Earnings Call Transcript

2018-08-02 seekingalpha
Welcome to the MEDNAX 2018 Second Quarter Earnings Conference Call. As a reminder, this conference is being recorded.



CUSIP: 58502B106